세계의 단백질 발현 시장 규모 : 용도별, 제품별, 지역별, 범위 및 예측

Protein Expression Market Size And Forecast

Protein Expression Market size was valued at USD 2.87 Billion in 2021 and is projected to reach USD 7.63 Billion by 2030 , growing at a CAGR of 11.47% from 2023 to 2030. The growth of this market is driven majorly by the rising incidence of chronic diseases, growth in the geriatric population, and rising demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. The Global Protein Expression Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Protein Expression Market Definition

Protein expression refers to a biotechnological process of generating specific proteins, typically attained by manipulating gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities for expressing and isolating heterogonous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled the expression & isolation of recombinant proteins on a large scale.

One of the significant achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to entirely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellular operating enzymes through therapeutic proteins. The first expression platform established was the prokaryotic system through Escherichia coli. The development of other expression systems, including insects, yeast, algae, and mammals followed this. Protein expression refers to how proteins are synthesized, modified, and regulated in living organisms. Protein expression is majorly being invested in by private and Govt. healthcare bodies due to the increasing scope of biotechnology and pharmaceutical industries.

Global Protein Expression Market Overview

Protein expression finds significant application in research, industrial and therapeutics, and others. Therapeutic proteins such as peptide hormones, vaccines, monoclonal antibodies, therapeutic enzymes, antibodies, blood factors, and cytokines are widely used to treat chronic diseases such as cancer, diabetes, and multiple sclerosis. These proteins have elevated quality, accuracy, and efficiency in biologics production.

The factors that boost the Protein Expression Market growth include an increase in the geriatric population, age-related diseases, and a rise in the prevalence of chronic diseases such as cancer. Moreover, increased spending on protein research also fuels the growth of the Protein Expression Market. However, high monetary inputs associated with the production of protein products restrict the market's growth. In addition, a significant shortage of trained healthcare professionals and a lack of local expertise also restrains the market.

Improvements in innovations such as mass spectrometry, molecular genetics, and manufacturing techniques are critical drivers in the Protein Expression Market. Furthermore, rapid developments in better disease detection, medical technology, and healthcare growth in emerging markets should positively impact the market.

Global Protein Expression Market: Segmentation Analysis

The Global Protein Expression Market is Segmented on the basis of Application, Product, And Geography.

Protein Expression Market, By Product

• Reagents
• Expression Vectors
• Competent Cells
• Instruments
• Services

Based on Product, the market is bifurcated into Reagents, Expression vectors, competent cells, Instruments, and Services. The reagents segment was the largest revenue-grossing segment of the market due to the large application of these products for research and biopharmaceuticals manufacturing. The repetitive purchase of reagents for various applications including therapeutic, industrial, and research is expected to boost the market growth.

• The services segment is anticipated to witness the fastest growth rate during the study period due to the escalating trend of services for custom optimization of protein expression. In addition, the service providers are equipped with advanced products and research specialists, which is expected to propel the demand for protein expression services by manufacturers and research laboratories.

Protein Expression Market, By Application

• Therapeutic
• Industrial
• Research

Based on Application, the market is bifurcated into Therapeutic, Industrial, and Research. The therapeutic application segment dominated the overall sector in terms of revenue in 2016. This is due to the large application of protein expression for the production of biologics. These products provide high accuracy, efficiency, and quality in biologics production. This segment is also projected to grow at the highest rate during the forecast period owing to the growing popularity of therapeutic proteins over other drugs.

Protein Expression Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Based on regional analysis, the Global Flexible Substrates Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific market is expected to grow at the highest CAGR during the forecast period, owing to the rising penetration of contract research organizations and developing healthcare infrastructure in Asian countries including India and China. The availability of a massive genome pool, a large number of patients, accessibility of skilled personnel, and less stringent regulation for biologics production in Asian countries have propelled the sector growth in this region.

Key Players

• The "Global Protein Expression Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific Inc., Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Lonza Group Ltd., New England Biolabs Inc., Sengenics, Proteogenix, Synthetic Genomics Inc.
• These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PROTEIN EXPRESSION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents
• 5.3 Expression Vectors
• 5.4 Competent Cells
• 5.5 Instruments
• 5.6 Services

6 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutic
• 6.3 Industrial
• 6.4 Research

7 GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
• 7.6 Rest of the World

8 GLOBAL PROTEIN EXPRESSION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Share
• 8.3 Vendor Landscape
• 8.4 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Thermo Fisher Scientific Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Merck KGaA
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Genscript Biotech Corporation
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Agilent Technologies, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Takara Bio Inc.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Promega Corporation
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Bio-Rad Laboratories, Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Qiagen N.V.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Lonza Group Ltd.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 New England Biolabs Inc.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Reports